Drug Database
RA

rat nerve growth factor (Nobex)

✓ Approved

Sinobioway Biomedicine · NGFR

什么是 rat nerve growth factor?

rat nerve growth factor 是一种治疗药物,由Sinobioway Biomedicine研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)。

药物档案

商品名Nobex
公司Sinobioway Biomedicine
分子靶点NGFR
给药途径Injectable (Others)
状态Approved

作用机制

分子靶点

rat nerve growth factor 作用于 1 个分子靶点:

NGFRnerve growth factor receptor (Gp80-LNGFR, TNFRSF16)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

rat nerve growth factor 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Injury, poisoning and procedural complicationsCranial nerve injury✓ Approved

相关研究文献

PubMedThe Laryngoscope2026-11-19

Posterior Transoral Approach to Proximal Perihilar Submandibular Stone Removal.

Lee Rex H RH, Civantos Alyssa M AM, Husman Tiffany T, Chang Jolie L JL

This video describes a surgical technique for removal of perihilar submandibular duct stones via a posterior transoral approach. While the lingual nerve crosses deep to the submandibular duct in the anterior floor of mouth, the course of the lingual nerve in the posterior floor of mouth (near the gland hilum) is superficial and lateral to the submandibular duct. This anatomic relationship is critical to understand to minimize the risk of lingual nerve injury during approach to the submandibular gland transorally.

PMID 43053291
阅读全文 →
PubMedNaunyn-Schmiedeberg's archives of pharmacology2026-11-19

Targeting neuroinflammation in diabetic peripheral neuropathy: Mechanistic perspectives, phytochemical pharmacology, and translational challenges.

Narapusetty Naidu N, Marabathuni V Jhansipriya VJ

Diabetic peripheral neuropathy (DPN) is a debilitating neurodegenerative complication of diabetes mellitus characterized by the convergence of metabolic dysregulation, microvascular ischemia, and chronic low-grade neuroinflammation. While intensive glycemic control and cardiometabolic risk-factor modification slow neuropathy progression-most notably in type 1 diabetes mellitus (T1DM)-approved central analgesic pharmacotherapies primarily manage nociceptive symptoms without directly reversing established structural axonal loss. Preclinical studies indicate that endoneurial inflammation mediated via Toll-like receptor 4 (TLR4), nuclear factor-kappa B (NF-κB), and the nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3) inflammasome contributes to microvascular dysfunction and Schwann cell dedifferentiation. Investigational phytochemicals, including curcumin, resveratrol, berberine, and quercetin, modulate these inflammatory and oxidative nodes in experimental rodent models. However, clinical translation remains constrained by poor aqueous solubility, extensive phase II enterocytic and hepatic conjugation, active efflux, and restricted transport across the diseased blood-nerve barrier (BNB). Using a structured narrative synthesis and a three-tier evidence hierarchy, this Brief Report distinguishes established human pathogenic and clinical trial evidence from preclinical mechanistic findings, critically evaluates clinical trial limitations (sample size, duration, and subjective endpoints), and defines rigorous pharmacokinetic and pharmacodynamic criteria required to validate nanocarrier-mediated endoneurial target engagement.

PMID 43052394
阅读全文 →
PubMedBiomarker research2026-11-19

Irbesartan-loaded cRGD-modified PLGA nanoparticles attenuate intervertebral disc degeneration through an FGFR1-related mechanism.

Yu Xiao-Jun XJ, Wang Ying-Guang YG, Wang Shan-Xi SX, Li Ling-Jiang LJ et al.

Intervertebral disc degeneration (IDD) lacks effective disease-modifying therapy. This study evaluated the protective effects of irbesartan (Ir), explored fibroblast growth factor receptor 1 (FGFR1) as a candidate molecular mediator, and assessed whether cRGD modification could enhance nanoparticle uptake and local treatment effects. Rat IDD models and IL-1β-induced degenerative nucleus pulposus cells were used to assess free Ir and Ir-loaded cRGD-modified PLGA nanoparticles (cRGD-NPs@Ir). Bioinformatics screening, cellular thermal shift assay (CETSA), and molecular docking were used to nominate FGFR1 as a candidate Ir-associated protein, and FGFR1 knockdown was used to test whether FGFR1 status modified the treatment response. Imaging, histology, immunohistochemistry, Western blotting, RT-qPCR, nanoparticle characterization, Coumarin-6 uptake assays, and tandem LC3 reporter analysis were used to evaluate treatment-associated changes. Ir attenuated structural and molecular features of IDD, reduced MAPK/NF-κB signaling, altered autophagy-associated markers, and preserved extracellular matrix homeostasis. FGFR1 expression was lower in degenerative disc tissue, and FGFR1 knockdown attenuated several protective changes associated with Ir or cRGD-NPs@Ir. cRGD-NPs@Ir produced greater carrier-associated Coumarin-6 uptake than NPs@Ir and larger treatment-associated changes than free Ir for several directly compared endpoints. These findings support an FGFR1-related component of the response but do not establish direct Ir-FGFR1 binding, receptor-specific cRGD targeting, or exclusive FGFR1 dependence. FGFR1 may contribute as a candidate molecular mediator to Ir-associated changes in autophagy and inflammatory signaling in IDD. cRGD-NPs@Ir provides an uptake-enhancing local nanodelivery strategy, although receptor specificity and direct Ir-FGFR1 binding require further validation.

PMID 43053258
阅读全文 →
PubMedCell & bioscience2026-11-19

Oxytocin remodels the brain-heart axis: intranasal treatment rescues PTSD-related deficits in persistent fear memory retention and cardiac autonomic dysfunction.

Chen Qiuxia Q, Li Lingling L, Weng Jie J, Shao Jiajie J et al.

Post-traumatic stress disorder (PTSD) is increasingly recognized as a brain-body disorder in which excessive retention of pathological fear memory coincides with profound cardiac autonomic dysregulation, substantially elevating cardiovascular morbidity, including the risk of myocardial infarction. Despite this dual burden, therapeutic strategies capable of concurrently rescuing the core persistent fear memory retention deficits and normalizing stress-induced cardiac autonomic dysfunction remain critically lacking. Here, using a single prolonged stress-induced rat model of PTSD, we found that intranasal oxytocin (OXT) administration not only alleviates pathological over-retention of fear memory but also rescues fear cue-elicited abnormalities in heart rate and heart rate variability. Crucially, cervical vagotomy abolished these cardioprotective effects, indicating that OXT's cardiac regulatory actions rely on an intact vagus nerve pathway to re-establish cardiac autonomic homeostasis. Furthermore, in vivo electrophysiological recordings revealed that intranasal OXT robustly activates ventral tegmental area (VTA) dopamine (DA) neurons, elevating both the firing and burst rates. Immunofluorescence staining further confirms abundant OXT receptor expression within these DA neurons. Collectively, these results uncover a coordinated central-peripheral regulatory cascade modulated by intranasal OXT that mitigates PTSD-associated behavioral and physiological deficits, with VTA dopaminergic signaling likely serving as a major upstream mediator.

PMID 43053237
阅读全文 →
PubMedEmerging infectious diseases2026-11-19

Rat Hepatitis E Virus and Seoul Hantavirus in Pet Rats, Germany.

Mehl Calvin C, Schilling-Loeffler Katja K, Haake Alexander F H AFH, Sehl-Ewert Julia J et al.

Pet rats represent a reservoir of multiple zoonotic pathogens. We demonstrated that pet rats, previously confirmed to be Seoul orthohantavirus-infected and involved in human infections in Germany, were concurrently infected with rat hepatitis E virus. The high degree of rat hepatitis E virus sequence identity suggests a single incursion event.

PMID 43052263
阅读全文 →
PubMedACS biomaterials science & engineering2026-11-19

Three-Dimensional Printable Human Platelet Lysate Methacrylate/Hyaluronic Acid Methacrylate/Nanohydroxyapatite Nanocomposite Hydrogels with Enhanced Mechanical and Rheological Properties for Tissue Engineering.

Şeker Şükran Ş, Ladeira Bruno M BM, Cleymand Franck F, Correia Tiago R TR et al.

Human platelet lysate-based hydrogels have gained increasing attention as a xeno-free platform for tissue engineering due to their potential to support cell viability and biological activity. Human-derived platelet lysate methacrylate (hPLMA) is a recently developed photocrosslinkable material that enables the formation of three-dimensional (3D) hydrogels through light-induced crosslinking of blood-derived proteins. However, evaluating hPLMA in different hydrogel formulations may provide further insight into its potential for advanced applications. In this study, hyaluronic acid methacrylate (HAMA, 1% w/v) and nanohydroxyapatite (nHAp, 5% w/v) were incorporated into hPLMA to develop a photocrosslinkable nanocomposite hydrogel (hPLMA/HAMA/nHAp). The incorporation of HAMA increased the compressive strength from 2.1 ± 0.9 kPa to 4.5 ± 1.5 kPa, resulting in an approximately 40-fold increase in the storage modulus while preserving shear-thinning behavior. The composite hydrogels exhibited sustained release of platelet-derived growth factor-AB (PDGF-AB) and vascular endothelial growth factor (VEGF) over 9 days and supported human adipose stem cell (hASC) viability (>93% for all formulations). Furthermore, extrusion-based 3D printing enabled the fabrication of grid-shaped constructs with maintained porosity, demonstrating moderate printability and shape fidelity of the constructs. While the independent contribution of nHAp remains to be investigated in future studies, the results demonstrate that the incorporation of HAMA improves the mechanical and rheological properties of the hPLMA/nHAp hydrogel, highlighting its potential for future tissue engineering applications.

PMID 43052217
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多rat nerve growth factor